Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma cruzi | 12 | 2024 | 234 | 2.500 |
Why?
|
| Spike Glycoprotein, Coronavirus | 10 | 2024 | 190 | 2.440 |
Why?
|
| Chagas Disease | 12 | 2024 | 292 | 2.170 |
Why?
|
| Protozoan Vaccines | 9 | 2024 | 95 | 1.940 |
Why?
|
| Vaccines | 5 | 2024 | 365 | 1.460 |
Why?
|
| Protozoan Proteins | 4 | 2024 | 108 | 1.320 |
Why?
|
| Biosensing Techniques | 5 | 2012 | 48 | 1.260 |
Why?
|
| Recombinant Proteins | 15 | 2023 | 1388 | 1.030 |
Why?
|
| Surface Plasmon Resonance | 7 | 2012 | 45 | 1.030 |
Why?
|
| Adjuvants, Immunologic | 5 | 2024 | 381 | 0.900 |
Why?
|
| Fiber Optic Technology | 4 | 2012 | 45 | 0.880 |
Why?
|
| Transduction, Genetic | 1 | 2024 | 290 | 0.860 |
Why?
|
| Viruses | 1 | 2024 | 124 | 0.800 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.760 |
Why?
|
| Trypanocidal Agents | 4 | 2023 | 27 | 0.760 |
Why?
|
| Nitroimidazoles | 4 | 2023 | 44 | 0.750 |
Why?
|
| Vaccines, Synthetic | 7 | 2025 | 317 | 0.740 |
Why?
|
| HIV-1 | 1 | 2024 | 465 | 0.710 |
Why?
|
| Phospholipids | 2 | 2020 | 105 | 0.690 |
Why?
|
| Aptamers, Nucleotide | 4 | 2012 | 28 | 0.680 |
Why?
|
| Antigens, Helminth | 5 | 2025 | 190 | 0.670 |
Why?
|
| Antibodies, Viral | 7 | 2024 | 1151 | 0.630 |
Why?
|
| Mice, Inbred BALB C | 10 | 2025 | 1002 | 0.620 |
Why?
|
| Antigens, Protozoan | 4 | 2024 | 65 | 0.550 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2017 | 7 | 0.550 |
Why?
|
| Fluorometry | 1 | 2017 | 27 | 0.550 |
Why?
|
| Saccharomycetales | 3 | 2021 | 37 | 0.550 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 997 | 0.540 |
Why?
|
| Pandemics | 2 | 2021 | 1096 | 0.520 |
Why?
|
| Nanoparticles | 4 | 2012 | 232 | 0.510 |
Why?
|
| Viral Vaccines | 4 | 2021 | 333 | 0.510 |
Why?
|
| Animals | 32 | 2025 | 34050 | 0.510 |
Why?
|
| Immunoglobulin E | 3 | 2012 | 161 | 0.490 |
Why?
|
| Antibodies, Neutralizing | 7 | 2025 | 468 | 0.490 |
Why?
|
| Necator americanus | 3 | 2025 | 91 | 0.440 |
Why?
|
| Mice | 17 | 2025 | 17629 | 0.440 |
Why?
|
| Horse Diseases | 2 | 2023 | 32 | 0.430 |
Why?
|
| Allergens | 2 | 2018 | 252 | 0.430 |
Why?
|
| Temperature | 2 | 2017 | 303 | 0.420 |
Why?
|
| Gene Expression | 6 | 2021 | 1560 | 0.410 |
Why?
|
| Peroxidase | 1 | 2012 | 62 | 0.410 |
Why?
|
| Oligonucleotides | 1 | 2012 | 89 | 0.400 |
Why?
|
| Vaccines, Subunit | 2 | 2024 | 66 | 0.400 |
Why?
|
| Alum Compounds | 2 | 2022 | 41 | 0.380 |
Why?
|
| Trichuriasis | 2 | 2025 | 31 | 0.380 |
Why?
|
| Protein Domains | 6 | 2021 | 237 | 0.370 |
Why?
|
| Helminth Proteins | 2 | 2025 | 101 | 0.360 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2023 | 426 | 0.350 |
Why?
|
| Coronavirus Infections | 3 | 2021 | 356 | 0.340 |
Why?
|
| Arachis | 1 | 2010 | 73 | 0.340 |
Why?
|
| Antibodies, Helminth | 3 | 2025 | 124 | 0.320 |
Why?
|
| Protein Interaction Mapping | 1 | 2009 | 85 | 0.320 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 470 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1586 | 0.290 |
Why?
|
| DNA | 2 | 2012 | 1595 | 0.290 |
Why?
|
| Horses | 3 | 2023 | 91 | 0.290 |
Why?
|
| Antibodies, Protozoan | 4 | 2022 | 75 | 0.270 |
Why?
|
| Humans | 28 | 2025 | 124297 | 0.260 |
Why?
|
| Immunogenicity, Vaccine | 2 | 2024 | 102 | 0.250 |
Why?
|
| Necatoriasis | 1 | 2025 | 37 | 0.230 |
Why?
|
| Pichia | 4 | 2017 | 56 | 0.230 |
Why?
|
| Soil | 1 | 2025 | 55 | 0.230 |
Why?
|
| Staining and Labeling | 2 | 2017 | 186 | 0.230 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 96 | 0.230 |
Why?
|
| Neutralization Tests | 1 | 2024 | 237 | 0.220 |
Why?
|
| Rhodococcus equi | 1 | 2023 | 4 | 0.220 |
Why?
|
| Actinomycetales Infections | 1 | 2023 | 12 | 0.220 |
Why?
|
| Virus Replication | 2 | 2024 | 610 | 0.220 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 89 | 0.210 |
Why?
|
| Trichuris | 2 | 2025 | 26 | 0.210 |
Why?
|
| Genetic Vectors | 2 | 2024 | 939 | 0.200 |
Why?
|
| Models, Animal | 1 | 2024 | 460 | 0.200 |
Why?
|
| HEK293 Cells | 1 | 2024 | 744 | 0.190 |
Why?
|
| Chagas Cardiomyopathy | 2 | 2019 | 48 | 0.190 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 500 | 0.190 |
Why?
|
| Limit of Detection | 2 | 2012 | 63 | 0.190 |
Why?
|
| Immunization, Passive | 1 | 2022 | 120 | 0.190 |
Why?
|
| Hybridomas | 1 | 2021 | 42 | 0.190 |
Why?
|
| Zebrafish | 1 | 2024 | 383 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2024 | 373 | 0.180 |
Why?
|
| Gold | 2 | 2012 | 48 | 0.180 |
Why?
|
| RNA, Messenger | 3 | 2024 | 2815 | 0.180 |
Why?
|
| Nasal Sprays | 1 | 2021 | 8 | 0.180 |
Why?
|
| Genetic Engineering | 2 | 2021 | 160 | 0.180 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 2045 | 0.180 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 95 | 0.180 |
Why?
|
| Norovirus | 1 | 2024 | 317 | 0.180 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 91 | 0.170 |
Why?
|
| Interleukin-17 | 1 | 2021 | 119 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2021 | 171 | 0.170 |
Why?
|
| Pepsin A | 1 | 2019 | 12 | 0.170 |
Why?
|
| Aspartic Acid Proteases | 1 | 2019 | 9 | 0.170 |
Why?
|
| Health Resources | 1 | 2021 | 116 | 0.160 |
Why?
|
| Female | 16 | 2025 | 66330 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 143 | 0.160 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 203 | 0.150 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 532 | 0.150 |
Why?
|
| Nematospiroides dubius | 1 | 2018 | 2 | 0.150 |
Why?
|
| Milk Proteins | 1 | 2018 | 92 | 0.150 |
Why?
|
| Venoms | 1 | 2018 | 20 | 0.150 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2018 | 22 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4402 | 0.140 |
Why?
|
| Technology, Pharmaceutical | 2 | 2015 | 20 | 0.140 |
Why?
|
| Immunity | 1 | 2018 | 189 | 0.140 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2017 | 19 | 0.140 |
Why?
|
| Psychodidae | 1 | 2017 | 14 | 0.140 |
Why?
|
| Fluorescence | 1 | 2017 | 95 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.140 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 84 | 0.130 |
Why?
|
| Equipment Design | 4 | 2012 | 587 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 325 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1086 | 0.130 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2016 | 14 | 0.130 |
Why?
|
| Antigens, Viral | 1 | 2018 | 439 | 0.130 |
Why?
|
| Leishmania donovani | 1 | 2016 | 22 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 1017 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 261 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2016 | 113 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 370 | 0.120 |
Why?
|
| Silicon Dioxide | 2 | 2012 | 24 | 0.120 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2015 | 38 | 0.120 |
Why?
|
| Cytokines | 4 | 2022 | 1289 | 0.120 |
Why?
|
| Nucleic Acid Denaturation | 2 | 2012 | 28 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 394 | 0.110 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 776 | 0.110 |
Why?
|
| Equipment Failure Analysis | 2 | 2012 | 83 | 0.110 |
Why?
|
| Glutathione Transferase | 1 | 2014 | 153 | 0.110 |
Why?
|
| Technology | 2 | 2024 | 63 | 0.100 |
Why?
|
| Hemin | 1 | 2012 | 17 | 0.100 |
Why?
|
| Food Analysis | 1 | 2012 | 26 | 0.100 |
Why?
|
| G-Quadruplexes | 1 | 2012 | 10 | 0.100 |
Why?
|
| Administration, Intranasal | 2 | 2024 | 134 | 0.100 |
Why?
|
| Food Contamination | 1 | 2012 | 23 | 0.100 |
Why?
|
| Antigens, Plant | 1 | 2012 | 33 | 0.100 |
Why?
|
| Hookworm Infections | 1 | 2014 | 124 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1708 | 0.100 |
Why?
|
| Heart | 3 | 2023 | 708 | 0.100 |
Why?
|
| Plant Proteins | 1 | 2012 | 75 | 0.100 |
Why?
|
| Protein Conformation | 3 | 2019 | 830 | 0.100 |
Why?
|
| Molecular Probes | 1 | 2012 | 31 | 0.100 |
Why?
|
| Postural Balance | 1 | 2002 | 79 | 0.090 |
Why?
|
| Sports | 1 | 2002 | 62 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2012 | 395 | 0.090 |
Why?
|
| Models, Molecular | 3 | 2021 | 1068 | 0.090 |
Why?
|
| S-Adenosylmethionine | 1 | 2010 | 29 | 0.090 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 42 | 0.090 |
Why?
|
| Time Factors | 2 | 2011 | 6279 | 0.090 |
Why?
|
| RNA, Long Noncoding | 1 | 2013 | 210 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2012 | 368 | 0.090 |
Why?
|
| Egg White | 1 | 2010 | 10 | 0.090 |
Why?
|
| Muramidase | 1 | 2010 | 94 | 0.080 |
Why?
|
| DNA, Single-Stranded | 1 | 2010 | 74 | 0.080 |
Why?
|
| Optics and Photonics | 1 | 2010 | 139 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 325 | 0.080 |
Why?
|
| Fruit | 1 | 2010 | 219 | 0.080 |
Why?
|
| Vaccination | 3 | 2019 | 954 | 0.080 |
Why?
|
| Viral Load | 2 | 2021 | 384 | 0.080 |
Why?
|
| Severe Acute Respiratory Syndrome | 2 | 2020 | 37 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2025 | 822 | 0.080 |
Why?
|
| Epitopes | 2 | 2022 | 432 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2023 | 1006 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2021 | 890 | 0.070 |
Why?
|
| Parasite Load | 2 | 2018 | 31 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2023 | 909 | 0.070 |
Why?
|
| Proteomics | 1 | 2010 | 501 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 836 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2019 | 501 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2012 | 998 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2021 | 3038 | 0.060 |
Why?
|
| Honduras | 1 | 2025 | 26 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 2698 | 0.060 |
Why?
|
| Freeze Drying | 1 | 2024 | 15 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 1748 | 0.060 |
Why?
|
| Injections, Intramuscular | 1 | 2024 | 195 | 0.060 |
Why?
|
| Biotechnology | 2 | 2015 | 55 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2024 | 167 | 0.060 |
Why?
|
| Hepatomegaly | 1 | 2023 | 21 | 0.060 |
Why?
|
| Helminthiasis | 1 | 2025 | 77 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2023 | 51 | 0.050 |
Why?
|
| Protein Transport | 1 | 2025 | 368 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 382 | 0.050 |
Why?
|
| Lung | 2 | 2021 | 1487 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 70 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2023 | 56 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2022 | 39 | 0.050 |
Why?
|
| Antiparasitic Agents | 1 | 2022 | 31 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2022 | 138 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2023 | 176 | 0.050 |
Why?
|
| Biomarkers | 3 | 2025 | 3049 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2024 | 540 | 0.050 |
Why?
|
| Base Sequence | 3 | 2012 | 3089 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2025 | 2041 | 0.050 |
Why?
|
| Caliciviridae Infections | 1 | 2024 | 328 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2021 | 100 | 0.050 |
Why?
|
| Feces | 1 | 2025 | 724 | 0.050 |
Why?
|
| Polyethyleneimine | 1 | 2021 | 10 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2021 | 180 | 0.040 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2021 | 57 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 288 | 0.040 |
Why?
|
| Vaccines, DNA | 1 | 2021 | 48 | 0.040 |
Why?
|
| Electrophoresis, Capillary | 2 | 2010 | 12 | 0.040 |
Why?
|
| Aluminum Hydroxide | 1 | 2020 | 40 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 570 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 100 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 622 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 575 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2021 | 491 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2019 | 44 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 186 | 0.040 |
Why?
|
| Disease Progression | 2 | 2023 | 2044 | 0.040 |
Why?
|
| Parasitemia | 1 | 2019 | 24 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 152 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2021 | 757 | 0.040 |
Why?
|
| Mice, Inbred AKR | 1 | 2018 | 14 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 430 | 0.040 |
Why?
|
| Transfection | 1 | 2021 | 1062 | 0.040 |
Why?
|
| Protein Folding | 1 | 2019 | 216 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 471 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2019 | 153 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 889 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2445 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2018 | 30 | 0.040 |
Why?
|
| Cricetulus | 1 | 2018 | 100 | 0.040 |
Why?
|
| Freezing | 1 | 2017 | 28 | 0.040 |
Why?
|
| CHO Cells | 1 | 2018 | 160 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1689 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 125 | 0.040 |
Why?
|
| Industrial Microbiology | 1 | 2017 | 6 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 162 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4346 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 430 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 1738 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 568 | 0.030 |
Why?
|
| Fermentation | 1 | 2017 | 66 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 196 | 0.030 |
Why?
|
| Paraproteinemias | 1 | 1996 | 17 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 1996 | 58 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2016 | 97 | 0.030 |
Why?
|
| Dynamic Light Scattering | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 2748 | 0.030 |
Why?
|
| Cysteine | 1 | 2016 | 136 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 356 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2016 | 390 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2016 | 127 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 346 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 1696 | 0.030 |
Why?
|
| Plants, Genetically Modified | 1 | 2015 | 42 | 0.030 |
Why?
|
| Male | 5 | 2025 | 61050 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1109 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 1996 | 169 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1688 | 0.030 |
Why?
|
| Drug Stability | 1 | 2014 | 57 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 47 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 996 | 0.030 |
Why?
|
| Culture Media | 1 | 2014 | 183 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 195 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 1491 | 0.030 |
Why?
|
| DNA Probes | 1 | 2012 | 123 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 484 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2002 | 88 | 0.020 |
Why?
|
| Middle Aged | 3 | 2025 | 26620 | 0.020 |
Why?
|
| Dielectric Spectroscopy | 1 | 2010 | 3 | 0.020 |
Why?
|
| Diamond | 1 | 2010 | 2 | 0.020 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 6 | 0.020 |
Why?
|
| Buffers | 1 | 2010 | 31 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 9004 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2010 | 51 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 65 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2010 | 56 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2010 | 49 | 0.020 |
Why?
|
| Calibration | 1 | 2010 | 89 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2010 | 106 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 251 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3727 | 0.020 |
Why?
|
| Fluorescence Polarization | 1 | 2010 | 9 | 0.020 |
Why?
|
| Photobleaching | 1 | 2010 | 4 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 341 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 184 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2010 | 119 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 14003 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 375 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 657 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 324 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1295 | 0.020 |
Why?
|
| Adolescent | 1 | 2025 | 19266 | 0.020 |
Why?
|
| Adult | 2 | 2025 | 29377 | 0.020 |
Why?
|
| Age Factors | 1 | 2002 | 2808 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1532 | 0.010 |
Why?
|
| Child | 1 | 2025 | 24372 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2629 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1942 | 0.010 |
Why?
|
| Aged | 2 | 2002 | 19558 | 0.010 |
Why?
|
| Neoplasms | 1 | 2013 | 2764 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1996 | 419 | 0.010 |
Why?
|
| Prognosis | 1 | 1996 | 4609 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 6467 | 0.000 |
Why?
|